Scalp Treatment for Hair Loss: The 3-Ingredient Formula

The most effective clinician-prescribed scalp treatments for hair loss target androgenetic alopecia from three angles: minoxidil opens blood flow to dormant follicles, finasteride reduces the DHT that shrinks them, and retinoic acid enhances how deeply both compounds penetrate the skin. Together, they address the biology driving pattern hair loss in ways no single ingredient covers alone.

Men searching for a scalp treatment for hair loss have usually moved past shampoos and biotin supplements. Androgenetic alopecia — the pattern hair loss that affects roughly half of men by age 50 — responds best to compounds that intervene at the hormonal and vascular level, applied directly where follicle damage is occurring. Understanding what each ingredient does, and why clinicians are increasingly prescribing them together, starts with the biology of the follicle itself.

What Androgenetic Alopecia Does to Hair Follicles

Pattern hair loss is not random. In men with a genetic predisposition, the androgen dihydrotestosterone (DHT) gradually miniaturizes hair follicles — shortening the growth phase, shrinking individual fibers, and eventually rendering follicles dormant. The process is progressive and accumulates over years, which is why earlier intervention generally correlates with better outcomes than waiting until the hairline has substantially receded.

The scalp's regional variation matters too. Blood supply, follicle density, and the local hormonal environment all differ between the crown, the hairline, and the sides — which explains why AGA follows a predictable geographic pattern rather than affecting the entire scalp equally. A topical approach places active compounds at those specific zones, rather than distributing them systemically.

This biology shapes the logic of a multi-ingredient topical formula. The three active components in a minoxidil/finasteride/retinoic acid preparation each target a different part of the same cascade, which is why the combination has scientific rationale that individual components do not fully cover on their own.

How Minoxidil Works at the Scalp Level

Minoxidil's role in hair growth was discovered as an unexpected side effect of an oral blood pressure medication before becoming the therapeutic target of FDA-approved topical formulations. The FDA has approved topical minoxidil — at 2% and 5% concentrations — for androgenetic alopecia based on controlled trial evidence demonstrating increased hair counts compared to vehicle-treated controls.

The mechanism centers on vasodilation and potassium channel opening in the dermal papilla cells surrounding the hair follicle. This prolongs the anagen (active growth) phase and improves blood supply to follicles that have been partially starved of circulation. Minoxidil must be converted to its pharmacologically active form — minoxidil sulfate — by sulfotransferase enzymes present in the scalp, and the concentration of those enzymes varies substantially between individuals.

That enzyme variability helps explain a clinical observation that frustrated early dermatologists: some men treated with identical minoxidil concentrations see significant regrowth while others see minimal benefit. The sulfotransferase step is the bottleneck — which connects directly to what retinoic acid contributes to the formula.

Finasteride: Addressing the Hormonal Source

Oral finasteride 1 mg (FDA-approved for androgenetic alopecia) works by inhibiting Type II 5-alpha reductase, the enzyme that converts testosterone to DHT in the scalp and other androgen-sensitive tissues. In the landmark 1998 JAAD study (Kaufman et al.), 1,553 men with AGA treated with finasteride 1 mg daily over two years showed significantly greater hair count increases and better investigator-rated global assessments compared to placebo.

The interest in topical finasteride formulations stems from the pharmacokinetic rationale: concentrating finasteride at the scalp tissue may reduce DHT locally while minimizing the systemic hormonal effects associated with the oral form. A 2025 updated systematic review and meta-analysis in JAAD evaluated topical finasteride combined with minoxidil for AGA, adding to a growing body of evidence that supports the combination approach — though individual formulation variables, concentrations, and patient selection remain active areas of investigation.

Men interested in understanding the oral finasteride option can learn more about the clinician-reviewed finasteride program at Body Good Men. Whether oral or topical finasteride is appropriate is a determination a licensed provider makes based on your medical history.

What Retinoic Acid Adds to the Formula

Retinoic acid — the pharmacologically active derivative of vitamin A — has a documented but underappreciated role in hair follicle biology. Research going back to a 1986 JAAD study (Bazzano et al.) tested topical tretinoin combined with a lower-than-standard concentration of minoxidil in 56 subjects with AGA. The combination produced terminal hair regrowth in 66% of subjects — a result that drew attention because the minoxidil concentration used was below the level expected to produce a robust response on its own.

The explanation for that amplification came into focus with a 2019 study by Suchonwanit et al., which demonstrated that topical tretinoin application upregulates follicular sulfotransferase enzyme expression — precisely the enzymes responsible for converting minoxidil into its active sulfate form. In that study, 43% of subjects initially identified as predicted non-responders to minoxidil were converted to responders after a short course of topical tretinoin application.

In practical terms, retinoic acid contributes two things to a combination formula: it enhances the skin's permeability (allowing minoxidil and finasteride to penetrate more effectively), and it primes the follicle's enzymatic machinery to actually activate the minoxidil it receives. This is why the triple combination has a mechanistic rationale that a simple two-ingredient formula does not fully replicate.

For men who have had limited results from topical minoxidil alone, the Min/Fin/Retinoic topical combination program at Body Good Men is a clinician-reviewed option that addresses the sulfotransferase limitation directly. A licensed provider determines whether this formulation is appropriate based on your history and current hair loss pattern.

How a Clinician Evaluates Candidates for Topical Combination Therapy

A licensed provider evaluating someone for a compounded minoxidil/finasteride/retinoic acid formula considers several categories of information. The type and extent of hair loss matters first — the triple-ingredient approach is specifically relevant to androgenetic alopecia, and distinguishing AGA from other causes (alopecia areata, telogen effluvium, scarring alopecias) changes the treatment entirely.

How long the loss has been progressing and which scalp regions are affected helps establish whether follicles are likely still viable and responsive to treatment. Follicles that have been dormant for many years without vellus hair present are less likely to respond than follicles in an active transition phase.

Medical history factors the provider reviews include skin sensitivity (retinoic acid can cause irritation, particularly in the early weeks of use), any prior response to minoxidil or finasteride, and relevant reproductive considerations. Men interested in oral minoxidil through Body Good Men or topical alternatives will go through the same eligibility review process.

The Min/Fin/Retinoic combination topical program at Body Good Men connects you with a US-licensed clinician who performs that evaluation and, if appropriate, works with a compounding partner pharmacy to prepare the formulation. Concentrations and vehicle selection are clinical decisions, not catalog choices.

Understanding the Timeline for Topical Scalp Treatments

Hair regrowth is slow by its biology. The follicle growth cycle operates over months, and most clinical trials measuring AGA treatment outcomes run for six to twelve months to capture meaningful data. Men using any clinician-directed treatment for hair loss should expect at least four months before evaluating early response signals, and a full twelve months for a comprehensive picture of outcome.

Shedding in the first four to eight weeks of treatment is a commonly reported experience and does not signal treatment failure. It reflects follicles transitioning from a stagnant resting phase into active cycling — a process that temporarily increases visible loss before new growth follows. Understanding this in advance significantly reduces unnecessary early discontinuation.

Combination approaches do not guarantee superior results for every individual. Individual biological variation — particularly in sulfotransferase enzyme concentration and follicle viability — means outcomes vary. What the published evidence supports is a stronger scientific rationale for multi-ingredient topical therapy than for any single compound used in isolation.

---

Frequently Asked Questions

Does a scalp treatment for hair loss actually regrow hair?

Clinician-prescribed scalp treatments targeting androgenetic alopecia can produce measurable hair regrowth in men with viable follicles. The 1986 JAAD study by Bazzano et al. documented terminal hair regrowth in 66% of AGA subjects using a tretinoin-minoxidil combination. Individual results depend on the stage of hair loss, how long follicles have been dormant, and biological variation in how efficiently the scalp activates minoxidil.

What is the difference between a topical and an oral hair loss treatment?

Topical treatments apply active compounds directly to the scalp, concentrating them in the tissue where follicle damage occurs while limiting broader systemic distribution. Oral treatments — such as finasteride 1 mg tablets — work systemically, reducing DHT throughout the body. Some men use topical and oral treatments in combination; a clinician reviews your individual situation to determine what approach, if any, is appropriate for you.

How long does a scalp treatment take to show results?

Most controlled clinical trials for AGA treatments run for six to twelve months to capture meaningful hair count data, reflecting how slowly follicle cycles operate. Men using a clinician-prescribed topical formula should plan for at least four months before expecting visible changes, and a full twelve months for a fair assessment of overall response. Early discontinuation is the most common reason treatment appears to fail.

Can topical finasteride cause the same side effects as the oral pill?

Systemic absorption of topical finasteride is generally lower than with oral administration, which is part of the clinical rationale for topical delivery — lower systemic DHT suppression alongside local scalp-level effects. However, pharmacokinetics vary by formulation, vehicle, and concentration, and the side-effect profile of topical preparations is still being characterized in ongoing research. A prescribing clinician reviews your health history before recommending any finasteride-containing treatment.

Do I need a prescription for a compounded scalp treatment that contains finasteride?

Yes. Finasteride is a prescription drug regardless of whether it is formulated as an oral tablet or a topical compound. Compounded minoxidil/finasteride/retinoic acid preparations are prepared by licensed compounding pharmacies based on a clinician's prescription and are not available over the counter. The evaluation and prescribing process is what ensures the formulation and concentrations are appropriate for your specific situation.

---

If you're considering topical combination therapy and want to know whether it's appropriate for you, talk to a licensed clinician. The Min/Fin/Retinoic topical combination program at Body Good Men connects you with a US-licensed clinician who reviews your eligibility and, if appropriate, prescribes through our partner pharmacy.

---

Important Disclosure

men.joinbodygood.com is operated as an affiliate of Body Good Studio LLC and is a whitelabel certified partner of Leg Up Rx. men.joinbodygood.com does not provide medical services, prescribe medications, or maintain patient records. All clinical evaluations, prescription decisions, and medication fulfillment are handled by licensed medical and pharmacy partners through Leg Up Rx. This article is for general informational purposes only and is not medical advice. Talk to a licensed healthcare provider before starting any treatment. Eligibility for any medication is determined solely by a licensed clinician.

---